You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫療器械板塊走高 137種醫療器械100%採購國產
格隆匯10月12日丨醫療器械板塊走高,威高骨科漲超7%,萬孚生物、邁瑞醫療、海爾生物漲超5%,英科醫療、南微醫學、昊海生科等跟漲。近日,國家財政部及工信部聯合發佈通知,明確規定了政府機構(事業單位)採購國產醫療器械及儀器的比例要求。其中137種醫療器械全部要求100%採購國產;12種醫療器械要求75%採購國產;24種醫療器械要求50%採購國產;5種醫療器械要求25%採購國產。這項標準從全國範圍內,把公立醫院在內的單位,採購國產儀器設備的比例進行強制規範。國產醫療設備配置或迎來進院利好。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account